Skip to content

Patency and complications of 2mm and 6mm polytetrafluoroethylene graft sizes in patients under hemodialysis

Comparison of the patency and complications of 2mm and 6mm polytetrafluoroethylene graft sizes in patients undergoing maintenance hemodialysis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231212060340N1
Enrollment
60
Registered
2023-12-28
Start date
2024-02-19
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Kidney failure with hypertension. Condition 2: Renal failure. Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease Congenital renal failure

Interventions

Intervention 1: Control group: In this group, a 6-mm graft will be used. The brachial artery is connected to the axillary or brachial or basilic vein (based on better anatomical position to perform ve

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with kidney failure requiring chronic hemodialysis, as diagnosed by a nephrologist, who need an arm graft for hemodialysis access due to the lack of vascular access, as diagnosed by a vascular surgeon.

Exclusion criteria

Exclusion criteria: History of implantation of a graft in the same arm

Design outcomes

Primary

MeasureTime frame
Graft patency. Timepoint: 6 months after intervention. Method of measurement: Clinical examination and successful hemodialysis.;Infection. Timepoint: 6 months after intervention. Method of measurement: Secretions culture.;Steal syndrome. Timepoint: 6 months after intervention. Method of measurement: Clinical signs including pain, coldness, sensory ataxia, and hand ulcer.;Pseudoaneurysm. Timepoint: 6 months after intervention. Method of measurement: Clinical examination.;Bleeding. Timepoint: 6 months after intervention. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mahdi Kamyar

Mashhad University of Medical Sciences

kamyarmm@mums.ac.ir+98 51 3872 2140

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026